Related Experiment Videos
The roles of factor VII's structural domains in tissue factor binding
J Y Chang1, D W Stafford, D L Straight
1Department of Biology, University of North Carolina at Chapel Hill 27599, USA.
Biochemistry
|September 26, 1995
Summary
The study reveals that the Epidermal Growth Factor 1 (EGF-1) and catalytic domains of Factor VIIa directly interact with tissue factor during blood clotting. Other domains are crucial for optimal binding and molecular structure.
Area of Science:
- Biochemistry
- Molecular Biology
- Hematology
Background:
- Blood clotting is initiated by the binding of Factor VIIa to tissue factor.
- Understanding the specific roles of Factor VIIa domains in this interaction is crucial for elucidating coagulation pathways.
Purpose of the Study:
- To investigate the contribution of individual domains of Factor VIIa to its binding with tissue factor.
- To identify which domains are directly involved in the interaction and which provide structural support.
Main Methods:
- Recombinant DNA techniques were used to create chimeric Factor VII proteins with exchanged domains (gla, Egf-1, Egf-2, catalytic).
- Competition binding studies using 125I-labeled Factor VIIa and tissue factor-coated microtiter wells were performed.
- Kinetic parameters (Kd, koff, kon) were determined using microtiter plate assays.
Main Results:
- The binding affinity (Kd) of Factor VIIa to tissue factor was determined to be approximately 1.5 nM.
- Chimeric protein studies indicated direct contact between tissue factor and Factor VIIa's Egf-1 and catalytic domains.
- The gla and Egf-2 domains were found to be necessary for optimal binding, potentially providing structural roles.
Conclusions:
- The Egf-1 and catalytic domains of Factor VIIa are directly involved in the interaction with tissue factor.
- The gla and Egf-2 domains play a supporting role in binding, possibly by maintaining molecular structure.